Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

OVID

Ovid Therapeutics Inc

May 01 • 04:00PM ET

2.79

+0.02 0.72 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: PTCT FOLD RARE SRPT CRSP EDIT NTLA BLUE QURE SGMO

| Held by: VTI VXF SURI BSVO PRFZ QQQS DFAS AVSC IBRN

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.26	Insider Own	11.24%	Shs Outstand	173.04M	Perf Week	7.31%
Market Cap	482.77M	Forward P/E	-	EPS next Y	-0.59	Insider Trans	-0.10%	Shs Float	153.59M	Perf Month	29.17%
Enterprise Value	426.55M	PEG	-	EPS next Q	-0.12	Inst Own	38.79%	Short Float	4.53%	Perf Quarter	78.85%
Income	-17.41M	P/S	66.59	EPS this Y	-113.94%	Inst Trans	9.60%	Short Ratio	2.31	Perf Half Y	92.41%
Sales	7.25M	P/B	2.78	EPS next Y	-19.48%	ROA	-14.33%	Short Interest	6.96M	Perf YTD	71.17%
Book/sh	1.00	P/C	6.93	EPS next 5Y	-	ROE	-17.51%	52W High	3.11 -10.14%	Perf Year	785.15%
Cash/sh	0.40	P/FCF	-	EPS past 3/5Y	32.53% 29.81%	ROIC	-12.21%	52W Low	0.27 932.95%	Perf 3Y	-23.14%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	68.99% -10.48%	Gross Margin	95.86%	Volatility	4.19% 7.04%	Perf 5Y	-23.98%
Dividend TTM	-	EV/Sales	58.83	EPS Y/Y TTM	29.56%	Oper. Margin	-585.20%	ATR (14)	0.17	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.97	Sales Y/Y TTM	1181.27%	Profit Margin	-240.11%	RSI (14)	59.25	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	8.97	EPS Q/Q	190.79%	SMA20	2.14%	Beta	0.19	Target Price	5.25
Payout	-	Debt/Eq	0.10	Sales Q/Q	844.74%	SMA50	21.22%	Rel Volume	0.32	Prev Close	2.77
Employees	23	LT Debt/Eq	0.09	Earnings	Mar 18 BMO	SMA200	75.53%	Avg Volume	3.02M	Price	2.79
IPO	May 05, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	151.24% 816.99%	Trades		Volume	953,610	Change	0.72%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)